The Future of Targeting FLT3 Activation in AML
Sign Up to like & getrecommendations! Published in 2017 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-017-0381-2
Abstract: Internal tandem duplications (ITD) and tyrosine-kinase domain (TKD) mutations of the FMS-like tyrosine-kinase 3 (FLT3) can be found in up to one third of patients with acute myeloid leukemia (AML) and confer a poor prognosis.… read more here.
Keywords: targeting flt3; future targeting; flt3 activation; activation aml ... See more keywords